Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).

NCT Number	NCT05500391
Lead Sponsor	Centre Oscar Lambret Collaborators: Canceropôle Nord Ouest, Groupement Interrégional de Recherche Clinique et d'Innovation
Conditions	Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors, Ovarian Germ Cell Tumor, Adenocarcinoma, Clear Cell, Borderline Ovarian Tumor, Sex Cord-Stromal Tumor, Mucinous Adenocarcinoma of Ovary +6 more
Enrollment	88 participants
Start Date	2024-02-28
Primary Completion	2026-10 (estimated)
Study Completion	2032-07 (estimated)
Updated on ClinicalTrials.gov	2026-03-18